PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE PRESCRIBERS Comprehensive Test
Bank | 6th Edition (Woo & Wright/Robinson) 300 Questions with Verified Answers & Detailed
Rationales All 57 Chapters Covered | Updated 2026/2027 | A+ Graded
TABLE OF CONTENTS
| Unit | Topic Area | Questions |
|------|------------|-----------|
| 1 | Foundations of Prescribing | 1–30 |
| 2 | Pharmacokinetics & Pharmacodynamics | 31–50 |
| 3 | Pharmacogenomics & Individual Variation | 51–70 |
| 4 | Drug-Drug & Drug-Food Interactions | 71–85 |
| 5 | Adverse Drug Reactions & Medication Errors | 86–100 |
| 6 | Special Populations: Pediatrics | 101–115 |
| 7 | Special Populations: Geriatrics | 116–130 |
| 8 | Special Populations: Pregnancy & Lactation | 131–145 |
| 9 | Pain Management | 146–165 |
| 10 | Cardiovascular Pharmacology | 166–195 |
| 11 | Respiratory Pharmacology | 196–210 |
| 12 | Endocrine & Metabolic Pharmacology | 211–230 |
| 13 | Neurological & Psychiatric Pharmacology | 231–255 |
| 14 | Infectious Disease Pharmacology | 256–275 |
| 15 | Gastrointestinal & Renal Pharmacology | 276–290 |
| 16 | Advanced Practice Prescribing & Regulation | 291–300 |
---
,EXAM OVERVIEW
| Feature | Details |
|---------|---------|
| Textbook | Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition |
| Authors | Teri Moser Woo, PhD, APRN, CPNP; Wendy L. Wright, DNP, ANP-BC, FNP-BC |
| Total Questions | 300 multiple-choice questions |
| Format | Question → Correct Answer → Detailed Rationale |
| Target Audience | FNP, AGNP, PMHNP, and other NP students |
| Key Domains | Pharmacokinetics, pharmacodynamics, pharmacogenomics, prescribing
regulations, drug therapy across the lifespan |
---
UNIT 1: FOUNDATIONS OF PRESCRIBING
Chapter 1: The Role of the Advanced Practice Nurse as Prescriber
Questions 1–10
---
Question 1
Nurse practitioner prescriptive authority is regulated by:
A) The National Council of State Boards of Nursing
,B) The U.S. Drug Enforcement Administration
C) The State Board of Nursing for each state
D) The State Board of Pharmacy
Correct Answer: C
Rationale: Prescriptive authority for nurse practitioners is regulated by the State Board of
Nursing in each state. While the DEA regulates controlled substances at the federal level, the
scope of prescriptive authority—including what an APRN can prescribe and under what
conditions—is determined by state law and the state board of nursing.
---
Question 2
The benefits to the patient of having an APRN prescriber include:
A) Nurses know more about pharmacology than other prescribers because they take it in both
basic nursing and APRN programs
B) Nurses care for the patient from a holistic approach and include the patient in decision-
making regarding their care
C) APRNs are less likely to prescribe narcotics and other controlled substances
D) APRNs are able to prescribe independently in all states
Correct Answer: B
Rationale: APRNs provide patient-centered, holistic care and include patients in shared decision-
making. This is a key benefit of having an APRN prescriber. APRNs do not necessarily have more
pharmacology knowledge than other prescribers, and prescriptive authority varies by state.
, ---
Question 3
Clinical judgment in prescribing includes:
A) Factoring in the cost to the patient of the medication prescribed
B) Always prescribing the newest medication available for the disease process
C) Handing out drug samples to poor patients
D) Prescribing all generic medications to cut costs
Correct Answer: A
Rationale: Clinical judgment in prescribing involves considering multiple factors, including the
cost to the patient, efficacy, safety, and patient preferences. Prescribing the newest medication
is not always best; samples should be used judiciously; and generics are preferred when
appropriate but not universally.
---
Question 4
The process for choosing an effective drug for a disorder includes:
A) Asking the patient what drug they think would work best for them
B) Consulting nationally recognized guidelines for disease management
C) Prescribing medications that are available as samples before writing a prescription
D) Following U.S. Drug Enforcement Administration guidelines for prescribing
Bank | 6th Edition (Woo & Wright/Robinson) 300 Questions with Verified Answers & Detailed
Rationales All 57 Chapters Covered | Updated 2026/2027 | A+ Graded
TABLE OF CONTENTS
| Unit | Topic Area | Questions |
|------|------------|-----------|
| 1 | Foundations of Prescribing | 1–30 |
| 2 | Pharmacokinetics & Pharmacodynamics | 31–50 |
| 3 | Pharmacogenomics & Individual Variation | 51–70 |
| 4 | Drug-Drug & Drug-Food Interactions | 71–85 |
| 5 | Adverse Drug Reactions & Medication Errors | 86–100 |
| 6 | Special Populations: Pediatrics | 101–115 |
| 7 | Special Populations: Geriatrics | 116–130 |
| 8 | Special Populations: Pregnancy & Lactation | 131–145 |
| 9 | Pain Management | 146–165 |
| 10 | Cardiovascular Pharmacology | 166–195 |
| 11 | Respiratory Pharmacology | 196–210 |
| 12 | Endocrine & Metabolic Pharmacology | 211–230 |
| 13 | Neurological & Psychiatric Pharmacology | 231–255 |
| 14 | Infectious Disease Pharmacology | 256–275 |
| 15 | Gastrointestinal & Renal Pharmacology | 276–290 |
| 16 | Advanced Practice Prescribing & Regulation | 291–300 |
---
,EXAM OVERVIEW
| Feature | Details |
|---------|---------|
| Textbook | Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition |
| Authors | Teri Moser Woo, PhD, APRN, CPNP; Wendy L. Wright, DNP, ANP-BC, FNP-BC |
| Total Questions | 300 multiple-choice questions |
| Format | Question → Correct Answer → Detailed Rationale |
| Target Audience | FNP, AGNP, PMHNP, and other NP students |
| Key Domains | Pharmacokinetics, pharmacodynamics, pharmacogenomics, prescribing
regulations, drug therapy across the lifespan |
---
UNIT 1: FOUNDATIONS OF PRESCRIBING
Chapter 1: The Role of the Advanced Practice Nurse as Prescriber
Questions 1–10
---
Question 1
Nurse practitioner prescriptive authority is regulated by:
A) The National Council of State Boards of Nursing
,B) The U.S. Drug Enforcement Administration
C) The State Board of Nursing for each state
D) The State Board of Pharmacy
Correct Answer: C
Rationale: Prescriptive authority for nurse practitioners is regulated by the State Board of
Nursing in each state. While the DEA regulates controlled substances at the federal level, the
scope of prescriptive authority—including what an APRN can prescribe and under what
conditions—is determined by state law and the state board of nursing.
---
Question 2
The benefits to the patient of having an APRN prescriber include:
A) Nurses know more about pharmacology than other prescribers because they take it in both
basic nursing and APRN programs
B) Nurses care for the patient from a holistic approach and include the patient in decision-
making regarding their care
C) APRNs are less likely to prescribe narcotics and other controlled substances
D) APRNs are able to prescribe independently in all states
Correct Answer: B
Rationale: APRNs provide patient-centered, holistic care and include patients in shared decision-
making. This is a key benefit of having an APRN prescriber. APRNs do not necessarily have more
pharmacology knowledge than other prescribers, and prescriptive authority varies by state.
, ---
Question 3
Clinical judgment in prescribing includes:
A) Factoring in the cost to the patient of the medication prescribed
B) Always prescribing the newest medication available for the disease process
C) Handing out drug samples to poor patients
D) Prescribing all generic medications to cut costs
Correct Answer: A
Rationale: Clinical judgment in prescribing involves considering multiple factors, including the
cost to the patient, efficacy, safety, and patient preferences. Prescribing the newest medication
is not always best; samples should be used judiciously; and generics are preferred when
appropriate but not universally.
---
Question 4
The process for choosing an effective drug for a disorder includes:
A) Asking the patient what drug they think would work best for them
B) Consulting nationally recognized guidelines for disease management
C) Prescribing medications that are available as samples before writing a prescription
D) Following U.S. Drug Enforcement Administration guidelines for prescribing
